First filing for Zeria's functional dyspepsia drug
This article was originally published in Scrip
Executive Summary
Zeria has made the first approval filing worldwide, in Japan, for its acetylcholinesterase inhibitor acotiamide (ZD-338/YM443), for the treatment of functional dyspepsia.